News|Articles|March 28, 2025 (Updated: March 28, 2025)

5 pediatric FDA decisions to watch for in Q2 2025

Author(s)Morgan Ebert, Executive Editor, Joshua Fitch, Senior Editor

A look ahead to 5 key regulatory decisions scheduled to take place during the second quarter of 2025, from a monoclonal antibody to topical psoriasis treatments.

As we transition into the second quarter of 2025, pediatric health care providers are keeping a close eye on a slate of anticipated FDA decisions that could reshape the treatment landscape for children and adolescents.